
    
      A Single-centre, Parallel-cohort, Randomized, Open-label, Two-period, Cross-over,
      Bioequivalence Study of the Fixed Dose Combination of Dapagliflozin/Metformin XR Relative to
      Co-administration of the Individual Components in Two Cohorts of Healthy Chinese Subjects in
      the Fed State.
    
  